U.S. Life and Health Insurance Industry Analysis

Industry Valuation and Performance

Has the U.S. Life and Health Insurance Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Tue, 07 Jul 2026	US$268.6b	US$264.8b	US$18.7b	15.6x	14.4x	1x
Thu, 04 Jun 2026	US$246.2b	US$264.8b	US$18.7b	13.6x	13.2x	0.9x
Sat, 02 May 2026	US$248.0b	US$261.5b	US$18.1b	14.7x	13.7x	0.9x
Mon, 30 Mar 2026	US$222.4b	US$260.6b	US$16.6b	13.9x	13.4x	0.9x
Wed, 25 Feb 2026	US$237.8b	US$260.4b	US$16.6b	15.4x	14.3x	0.9x
Fri, 23 Jan 2026	US$239.9b	US$255.6b	US$19.7b	13x	12.2x	0.9x
Sun, 21 Dec 2025	US$252.7b	US$255.6b	US$19.7b	13.1x	12.8x	1x
Tue, 18 Nov 2025	US$245.1b	US$255.6b	US$19.7b	11.9x	12.4x	1x
Thu, 16 Oct 2025	US$249.9b	US$254.5b	US$15.7b	13.3x	16x	1x
Sat, 13 Sep 2025	US$253.8b	US$254.5b	US$15.7b	13.8x	16.2x	1x
Mon, 11 Aug 2025	US$240.3b	US$254.5b	US$15.7b	13.3x	15.3x	0.9x
Wed, 09 Jul 2025	US$245.3b	US$257.6b	US$18.1b	12.4x	13.5x	1x
Fri, 06 Jun 2025	US$224.2b	US$243.3b	US$17.6b	12.3x	12.7x	0.9x
Sun, 04 May 2025	US$226.6b	US$240.1b	US$19.3b	12.4x	11.7x	0.9x
Tue, 01 Apr 2025	US$237.3b	US$250.3b	US$22.4b	11.5x	10.6x	0.9x
Thu, 27 Feb 2025	US$233.3b	US$248.7b	US$22.5b	10.7x	10.4x	0.9x
Sat, 25 Jan 2025	US$238.2b	US$242.9b	US$14.3b	14.3x	16.7x	1x
Mon, 23 Dec 2024	US$229.0b	US$242.9b	US$14.3b	13.5x	16.1x	0.9x
Wed, 20 Nov 2024	US$245.1b	US$242.9b	US$14.3b	14.5x	17.2x	1x
Fri, 18 Oct 2024	US$248.0b	US$229.8b	US$16.6b	14.1x	14.9x	1.1x
Sun, 15 Sep 2024	US$233.7b	US$229.8b	US$16.6b	12.9x	14.1x	1x
Tue, 13 Aug 2024	US$218.4b	US$229.8b	US$16.6b	12x	13.1x	1x
Thu, 11 Jul 2024	US$214.3b	US$222.7b	US$14.7b	9.6x	14.6x	1x
Sat, 08 Jun 2024	US$212.1b	US$225.4b	US$14.8b	10.5x	14.3x	0.9x
Mon, 06 May 2024	US$207.1b	US$223.8b	US$14.2b	13.2x	14.6x	0.9x
Wed, 03 Apr 2024	US$224.2b	US$216.9b	US$10.3b	17x	21.9x	1x
Fri, 01 Mar 2024	US$213.5b	US$216.4b	US$10.1b	15.4x	21.2x	1x
Sun, 28 Jan 2024	US$264.5b	US$213.6b	US$2.7b	13.7x	97.7x	1.2x
Tue, 26 Dec 2023	US$254.9b	US$216.4b	US$1.6b	13.4x	156.5x	1.2x
Thu, 23 Nov 2023	US$244.1b	US$216.4b	US$1.6b	12.8x	150.7x	1.1x
Sat, 21 Oct 2023	US$237.3b	US$238.9b	US$1.0b	12.4x	232.1x	1x
Mon, 18 Sep 2023	US$247.0b	US$238.9b	US$1.0b	13.1x	241.6x	1x
Wed, 16 Aug 2023	US$242.5b	US$238.9b	US$1.0b	13.2x	237.2x	1x
Fri, 14 Jul 2023	US$238.5b	US$240.0b	US$5.5b	12.6x	43.4x	1x

Current Industry PE

Investors are pessimistic on the American Life and Health Insurance industry, indicating that they anticipate long term growth rates will be lower than they have historically.

The industry is trading at a PE ratio of 14.4x which is lower than its 3-year average PE of 41.8x.

The industry is trading close to its 3-year average PS ratio of 0.99x.

Past Earnings Growth

The earnings for companies in the Life and Health Insurance industry have grown 50% per year over the last three years.
Revenues for these companies have grown 3.3% per year.
This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.S. Life and Health Insurance compare with similar industries?


US Market	0.79%
Financials	4.12%
Insurance	4.38%
Life and Health Insurance	2.94%
Insurance Brokers	7.63%
General Insurance	3.88%
Property and Casualty Insurance	3.75%
Reinsurance	2.53%

Industry PEThere are no additional sub-industries under this industry.

Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company	Last Price	7D	1Y	Valuation
MET MetLife	US$90.46	5.2% +US$2.9b	14.2%	PE16.9x
PRU Prudential Financial	US$114.28	4.7% +US$1.8b	7.4%	PE11.6x
PFG Principal Financial Group	US$112.55	3.7% +US$872.7m	40.4%	PE15.6x
BNT Brookfield Wealth Solutions	US$43.99	4.4% +US$615.4m	4.7%	PE30.3x
OSCR Oscar Health	US$31.44	6.8% +US$599.3m	87.0%	PS0.7x

Prudential Financial, Inc.'s PGIM Launches Four S&P 500 Quarterly Buffer Exchange-Traded Funds

PGIM, the $1.4 trillion1 global investment management business of Prudential Financial, Inc. had launched four S&P 500 quarterly buffer exchange-traded funds (ETFs) named the PGIM S&P 500 Quarterly Buffer 5 ETF (PQV), PGIM S&P 500 Quarterly Buffer 10 ETF (PQX), PGIM S&P 500 Quarterly Buffer 15 ETF (PQXV) and PGIM S&P 500 Quarterly Buffer 20 ETF (PQXX). The ETFs are listed on the Cboe BZX Exchange, Inc. and are competitively priced at a 0.50% net expense ratio, placing them among the lowest-cost buffer ETFs in the marketplace. The ETFs represent a significant evolution of PGIM’s buffer ETF lineup by introducing a quarterly target outcome period (an approximate three-month cycle) in contrast to the one-year target outcome periods offered by PGIM’s existing buffer ETF series. The ETFs seek to provide investors with returns that match the price return of the State Street SPDR S&P 500 ETF Trust (SPY) up to a predetermined upside cap while providing a downside buffer against the first 5%, 10%, 15% or 20%, as applicable, of SPY’s losses over an approximate three-month target outcome period. On the first day of each new quarterly target outcome period the ETFs reset by investing in index option contracts known as FLexible EXchange Options (FLEX Options) on SPY that are designed to provide a new cap for the new target outcome period. With the addition of PQV, PQX, PQXV and PQXX, PGIM now offers one of the broadest buffer ETF suites in the industry, spanning nearly 50 solutions across multiple indices, buffer levels, outcome periods and single-ticker laddered solutions. Since January 2024, PGIM has launched PGIM S&P 500 Buffer 12 ETF series and PGIM S&P 500 Buffer 20 ETF series – 24 ETFs seeking to provide investors with returns that match the price return of SPY up to a predetermined upside cap while providing a downside buffer against the first 12% and 20%, as applicable, of SPY’s losses over a one-year target outcome period. PGIM Laddered S&P 500 Buffer 12 ETF (BUFP) and PGIM Laddered S&P 500 Buffer 20 ETF (PBFR) – single-ticker laddered funds of buffer ETFs that seek to provide investors with capital appreciation. Under normal market conditions, BUFP invests substantially all of its assets in each of the 12 PGIM S&P 500 Buffer 12 ETFs, generally in equal weights, while PBFR invests substantially all of its assets in each of the 12 PGIM S&P 500 Buffer 20 ETFs, generally in equal weights, with each ETF intending to generally rebalance its portfolio to an equal weight on a quarterly basis. PGIM S&P 500 Max Buffer ETF series – 12 ETFs that seek to provide investors with returns that match the price return of SPY up to a predetermined upside cap while seeking to maximize the downside protection against SPY’s losses over each ETF’s one-year target outcome period. PGIM Nasdaq-100 Buffer 12 ETF series – Four ETFs seeking to provide investors with returns that match the price return of the Invesco QQQ TrustSM, Series 1 (QQQ) up to a predetermined upside cap, while providing a downside buffer against the first 12% of QQQ’s losses over each ETF’s one-year target outcome period. PGIM Laddered Nasdaq-100 Buffer 12 ETF (PBQQ) – single-ticker laddered Nasdaq solution that seeks to provide investors with capital appreciation and under normal market conditions invests substantially all of its assets in each of the quarterly PGIM Nasdaq-100 Buffer 12 ETFs, generally in equal weights. The ETF intends to generally rebalance its portfolio to equal weight on a quarterly basis. The ETFs are sub advised by PGIM’s Quantitative Solutions investment group, the $105,000 million quantitative equity and multi-asset specialist of PGIM.

U.S. Life and Health Insurance Industry Analysis

Industry Valuation and Performance

Industry Comparison

Top Stock Gainers and Losers

Latest News

Unum Group: Fairly Valued Given Some Closed Block Drag (Rating Downgrade)

Upcoming dividend of US$0.45 per share

Prudential Financial, Inc.'s PGIM Launches Four S&P 500 Quarterly Buffer Exchange-Traded Funds

Primerica: Business Shift Will Help Keep This Company Growing

Principal Financial Group Unveils New Retirement Income Products for Employer Plans

New minor risk - Insider selling

GL: Higher 2026 Guidance And Buybacks Will Support Future Upside

MetLife, Inc. to Report Q2, 2026 Results on Aug 05, 2026

Independent Director notifies of intention to sell stock

Upcoming dividend of US$0.07 per share

Citizens, Inc. Just Missed Earnings - But Analysts Have Updated Their Models